Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Longevity Health Inc.

    NASDAQ: XAGE · Real-Time Price · USD
    2.40
    -0.12 (-4.76%)
    At close: Jul 01, 2025, 10:42 AM

    Longevity Health Statistics

    Share Statistics

    Longevity Health has 1M shares outstanding. The number of shares has increased by -96.67% in one year.

    Shares Outstanding

    n/a
    		 1M

    Shares Change (YoY)

    n/a
    		 -96.67%

    Shares Change (QoQ)

    n/a
    		 -96.67%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 927.22K

    Failed to Deliver (FTD) Shares

    n/a
    		 17,408

    FTD / Avg. Volume

    n/a
    		 2.79%

    Short Selling Information

    The latest short interest is 12.16K, so 1.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.16K

    Short % of Shares Out

    n/a
    		 1.21%

    Short % of Float

    n/a
    		 1.44%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -16.88 and the forward PE ratio is null. Longevity Health's PEG ratio is 0.52.

    PE Ratio

    n/a
    		 -16.88

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 3477.45

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -37.13

    P/FCF Ratio

    n/a
    		 -39.87

    PEG Ratio

    n/a
    		 0.52
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Longevity Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.16, with a Debt / Equity ratio of -0.14.

    Current Ratio

    n/a
    		 0.16

    Quick Ratio

    n/a
    		 0.14

    Debt / Equity

    n/a
    		 -0.14

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.15

    Interest Coverage

    n/a
    		 -101.98

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $3,354.53

    Profits Per Employee

    n/a
    		 $-691,217.4

    Employee Count

    n/a
    		 15

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 0.06

    Taxes

    Income Tax

    n/a
    		 -97.28K

    Effective Tax Rate

    n/a
    		 0.91%

    Stock Price Statistics

    The stock price has increased by -95.08% in the last 52 weeks. The beta is 0.56, so Longevity Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.56

    52-Week Price Change

    n/a
    		 -95.08%

    50-Day Moving Average

    n/a
    		 3.53

    200-Day Moving Average

    n/a
    		 7.93

    Relative Strength Index (RSI)

    n/a
    		 42.46

    Average Volume (20 Days)

    n/a
    		 623,204

    Income Statement

    In the last 12 months, Longevity Health had revenue of 50.32K and earned -10.37M in profits. Earnings per share was -0.5.

    Revenue

    n/a
    		 50.32K

    Gross Profit

    n/a
    		 43.96K

    Operating Income

    n/a
    		 -5M

    Net Income

    n/a
    		 -10.37M

    EBITDA

    n/a
    		 -10.5M

    EBIT

    n/a
    		 -10.7M

    Earnings Per Share (EPS)

    n/a
    		 -0.5
    Full Income Statement

    Balance Sheet

    The company has 157.14K in cash and 638.99K in debt, giving a net cash position of -481.85K.

    Cash & Cash Equivalents

    n/a
    		 157.14K

    Total Debt

    n/a
    		 638.99K

    Net Cash

    n/a
    		 -481.85K

    Retained Earnings

    n/a
    		 -68.87M

    Total Assets

    n/a
    		 1.47M

    Working Capital

    n/a
    		 -4.92M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.39M and capital expenditures 0, giving a free cash flow of -4.39M.

    Operating Cash Flow

    n/a
    		 -4.39M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.39M

    FCF Per Share

    n/a
    		 -0.21
    Full Cash Flow Statement

    Margins

    Gross margin is 87.37%, with operating and profit margins of -9933.82% and -20605.47%.

    Gross Margin

    n/a
    		 87.37%

    Operating Margin

    n/a
    		 -9933.82%

    Pretax Margin

    n/a
    		 -21359.64%

    Profit Margin

    n/a
    		 -20605.47%

    EBITDA Margin

    n/a
    		 -20870.2%

    EBIT Margin

    n/a
    		 -9933.82%

    FCF Margin

    n/a
    		 -8722.42%

    Dividends & Yields

    XAGE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for XAGE.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 14, 2025. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 May 14, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -92.98

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist